Abstract
The purpose of this study is to consider the decision making and implementation of Corporate Social Responsibility （CSR） strategies and the effect they've had on the nature of pharmaceutical companies. We shall clarify the characteristics and the current state of CSR strategies in Japanese and Korean pharmaceutical companies.
Since their inception, both Japanese and Korean pharmaceutical companies have recognized the responsibilities that arise naturally from their roles in society and have sought to implement CSR into their core business strategies. As a result, it becomes clear that pharmaceutical companies have considered CSR strategies with respect to the nature of their business model.
Furthermore, strategic models of CSR that have been deployed by Japanese pharmaceutical companies are centered around the type of social market formation, whereas responsive models of CSR that have been deployed by Korean pharmaceutical companies are centered around the type of the profits returned to society. These differences highlight the characteristics and the current state of CSR strategies in the pharmaceutical companies of both countries. Moreover, the major factors that are considered to have an effect on these differences are the extent of globalization, company size, company profits and relationships with international NGOs/NPOs.
